Growth Metrics

Travere Therapeutics (TVTX) Change in Taxes (2016 - 2022)

Travere Therapeutics' Change in Taxes history spans 7 years, with the latest figure at -$22000.0 for Q4 2022.

  • For Q4 2022, Change in Taxes rose 76.34% year-over-year to -$22000.0; the TTM value through Dec 2022 reached $154000.0, up 100.9%, while the annual FY2025 figure was -$849000.0, 2170.73% down from the prior year.
  • Change in Taxes reached -$22000.0 in Q4 2022 per TVTX's latest filing, down from $264000.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $18.8 million in Q1 2020 to a low of -$16.8 million in Q2 2021.
  • Average Change in Taxes over 4 years is -$128153.8, with a median of -$74000.0 recorded in 2020.
  • Peak YoY movement for Change in Taxes: surged 6280.26% in 2020, then plummeted 22566.22% in 2021.
  • A 4-year view of Change in Taxes shows it stood at -$555000.0 in 2019, then soared by 735.32% to $3.5 million in 2020, then tumbled by 102.64% to -$93000.0 in 2021, then surged by 76.34% to -$22000.0 in 2022.
  • Per Business Quant, the three most recent readings for TVTX's Change in Taxes are -$22000.0 (Q4 2022), $264000.0 (Q3 2022), and -$93000.0 (Q4 2021).